Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85 | 92 | 53 | 163 | 14 |
| Receivables | N/A | N/A | N/A | 48 | N/A |
| Other current assets | 49 | 49 | 4 | 86 | 35 |
| TOTAL | $177 | $196 | $86 | $321 | $52 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5 | 12 | 17 | N/A |
| Other Non-Current Assets | 18 | 33 | 48 | 63 | 0 |
| TOTAL | $18 | $38 | $60 | $80 | $N/A |
| Total Assets | $195 | $234 | $146 | $400 | $52 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,922 | 2,495 | 1,434 | 1,846 | 1,830 |
| Accrued Expenses | 479 | 1,945 | 710 | 144 | 1,480 |
| Other current liabilities | N/A | 185 | N/A | N/A | 334 |
| TOTAL | $4,550 | $5,727 | $3,008 | $2,601 | $4,240 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 34 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,550 | $5,727 | $3,008 | $2,601 | $4,240 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 312 | 217 | 155 | 74 | 45 |
| Common Shares | 3 | 2 | 2 | 232 | 144 |
| Retained earnings | -161,802 | -157,511 | -148,280 | -142,311 | -129,543 |
| Other shareholders' equity | 22 | 22 | 280 | 895 | 22 |
| TOTAL | $-4,355 | $-5,493 | $-2,862 | $-2,200 | $-4,188 |
| Total Liabilities And Equity | $195 | $234 | $146 | $400 | $52 |